Page last updated: 2024-08-17

quinoxalines and cytisine

quinoxalines has been researched along with cytisine in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (20.69)29.6817
2010's21 (72.41)24.3611
2020's2 (6.90)2.80

Authors

AuthorsStudies
Cahill, K; Lancaster, T; Stead, LF5
Cahill, K; Lancaster, T; Stead, L1
Tutka, P1
Carroll, FI; Corrigall, WA; LeSage, MG; Ross, JT; Shelley, D1
Einarson, A; Riordan, S1
Papke, RL; Stitzel, JA; Wecker, L1
Bertrand, D; Bertrand, S; Coe, JW; Cremers, T; de Vries, M; Hurst, RS; Mather, RJ; O'Neill, BT; Rollema, H; Shrikhande, A; Tingley, FD; Tseng, E; Wang, EQ; Ward, KM; Williams, KE1
Cunningham, CS; McMahon, LR2
Al Rubaiy, SA; Bloom, SA; Guendisch, D; Papke, RL; Trocmé-Thibierge, C1
Gallagher, T; Haseler, CA; Hirschhäuser, C1
Cunningham, CS; Javors, MA; McMahon, LR1
Gallagher, T; Haseler, CA; Rucktooa, P; Sixma, TK; Smit, AB; van Elk, R1
Papke, RL; Stokes, C1
Busto, UE; Cassels, BK; Gysling, K; Quintanilla, ME; Sotomayor-Zárate, R; Tampier, L1
Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I1
Cahill, K; Lancaster, T; Perera, R; Stevens, S1
Cahill, K; Hartmann-Boyce, J; Lancaster, T; Stead, LF1
Rahman, S; Sajja, RK1
Eibl, C; Guendisch, D; Mineur, YS; Papke, RL; Peng, C; Picciotto, MR; Stokes, C; Tian, C; Tomassoli, I1
Alexander, JC; Bruijnzeel, AW; Igari, M; Ji, Y; Papke, RL; Qi, X1
Cieślewicz, A; Jabłecka, A; Korzeniowska, K1
Cantrell, A; Everson-Hock, E; Leaviss, J; Ren, S; Stevens, JW; Stevenson, M; Strong, M; Sullivan, W1
Benowitz, N; Clarke, A; Jacobs, C; Nides, M; Rigotti, NA1
Budzyńska, B; Chałas, R; Maciąg, M; Rahnama-Hezavah, M; Stachurski, P; Świątkowska, A; Świątkowski, W; Tylżanowski, P1

Reviews

11 review(s) available for quinoxalines and cytisine

ArticleYear
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1

    Topics: Alkaloids; Azocines; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline

2007
An update on therapeutics for tobacco dependence.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:1

    Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline

2008
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2008, Jul-16, Issue:3

    Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline

2008
Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.
    Expert opinion on investigational drugs, 2008, Volume: 17, Issue:10

    Topics: Alkaloids; Animals; Azocines; Benzazepines; Clinical Trials as Topic; Dopamine; Humans; Nicotinic Agonists; Quinolizines; Quinoxalines; Smoking Cessation; Varenicline

2008
Smoking in pregnancy and lactation: a review of risks and cessation strategies.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:4

    Topics: Adult; Alkaloids; Antidepressive Agents; Azocines; Benzazepines; Breast Feeding; Bromocriptine; Cognitive Behavioral Therapy; Female; Humans; Lactation; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinolizines; Quinoxalines; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Vaccines; Varenicline; Young Adult

2009
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2010, Dec-08, Issue:12

    Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline

2010
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2

    Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline

2011
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4

    Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline

2012
[Drugs used to treat nicotine addiction].
    Przeglad lekarski, 2012, Volume: 69, Issue:10

    Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult

2012
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    The Cochrane database of systematic reviews, 2013, May-31, Issue:5

    Topics: Adult; Alkaloids; Antidepressive Agents, Second-Generation; Azocines; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2013
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Health technology assessment (Winchester, England), 2014, Volume: 18, Issue:33

    Topics: Adult; Aged; Alkaloids; Azocines; Benzazepines; Cost-Benefit Analysis; Humans; Middle Aged; Nicotinic Agonists; Quality-Adjusted Life Years; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; State Medicine; United Kingdom; Varenicline

2014

Trials

1 trial(s) available for quinoxalines and cytisine

ArticleYear
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial).
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021, 08-29, Volume: 23, Issue:10

    Topics: Adult; Alkaloids; Azocines; Benzazepines; Double-Blind Method; Humans; Quinolizines; Quinoxalines; Smokers; Treatment Outcome; Varenicline

2021

Other Studies

17 other study(ies) available for quinoxalines and cytisine

ArticleYear
Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 91, Issue:3

    Topics: Alkaloids; Animals; Azocines; Benzazepines; Conditioning, Operant; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Male; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Long-Evans; Receptors, Nicotinic; Varenicline

2009
Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:2

    Topics: Acetylcholine; Alkaloids; Animals; Azocines; Benzazepines; Decamethonium Compounds; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Electrophysiology; Gene Expression; Hexamethonium; Humans; Mecamylamine; Mice; Mice, Transgenic; Muscle, Skeletal; Nicotinic Antagonists; Oocytes; Quinolizines; Quinoxalines; Rats; Receptors, Nicotinic; Varenicline; Xenopus laevis

2010
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
    British journal of pharmacology, 2010, Volume: 160, Issue:2

    Topics: Alkaloids; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Azepines; Azocines; Benzazepines; Brain; Dopamine; Heterocyclic Compounds, 4 or More Rings; Humans; Limbic System; Male; Mice; Mice, Knockout; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Tobacco Use Disorder; Varenicline; Xenopus laevis

2010
The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    European journal of pharmacology, 2011, Mar-01, Volume: 654, Issue:1

    Topics: Alkaloids; Animals; Azocines; Benzazepines; Conditioning, Operant; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Reinforcement Schedule; Smoking Cessation; Time Factors; Varenicline

2011
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:2

    Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Azocines; Benzazepines; Bupropion; DNA, Complementary; Dopamine Uptake Inhibitors; Electrophysiological Phenomena; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridinium Compounds; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus

2011
Core modification of cytisine: a modular synthesis.
    Angewandte Chemie (International ed. in English), 2011, May-23, Volume: 50, Issue:22

    Topics: Alkaloids; Azocines; Benzazepines; Cyclization; Nicotinic Agonists; Pyridones; Quinolizines; Quinoxalines; Receptors, Nicotinic; Tin Compounds; Varenicline

2011
Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:3

    Topics: Alkaloids; Animals; Azocines; Benzazepines; Cocaine; Conditioning, Operant; Discrimination Learning; Dopamine Uptake Inhibitors; Drug Interactions; Female; Hypnotics and Sedatives; Macaca mulatta; Male; Mecamylamine; Midazolam; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Varenicline

2012
Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
    The Journal of biological chemistry, 2012, Jul-06, Volume: 287, Issue:28

    Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Aplysia; Azocines; Benzazepines; Binding Sites; Binding, Competitive; Carrier Proteins; Cell Line; HEK293 Cells; Humans; Kinetics; Ligands; Models, Molecular; Mutation; Nicotine; Nicotinic Agonists; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline

2012
Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.
    Neuropharmacology, 2012, Volume: 63, Issue:4

    Topics: Acetylcholine; Alkaloids; Animals; Azocines; Benzazepines; Drug Partial Agonism; Evoked Potentials; Ganglia; Humans; Ligands; Mutagenesis, Site-Directed; Mutant Proteins; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Protein Subunits; Quinolizines; Quinoxalines; Rats; Receptors, Nicotinic; Recombinant Fusion Proteins; Species Specificity; Varenicline; Xenopus laevis

2012
Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
    Psychopharmacology, 2013, Volume: 227, Issue:2

    Topics: Alcohol Drinking; Alkaloids; Animals; Azocines; Benzazepines; Chile; Dose-Response Relationship, Drug; Drinking; Drug Administration Schedule; Ethanol; Male; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Saccharin; Time Factors; Varenicline

2013
Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
    Psychopharmacology, 2013, Volume: 228, Issue:2

    Topics: Alkaloids; Animals; Azocines; Benzazepines; Dihydro-beta-Erythroidine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Midazolam; Morphine; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2013
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:10

    Topics: Alkaloids; Azocines; Behavior Therapy; Behavior, Addictive; Benzazepines; Humans; Meta-Analysis as Topic; Nicotinic Agonists; Quinolizines; Quinoxalines; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2013
Nicotinic receptor partial agonists modulate alcohol deprivation effect in C57BL/6J mice.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 110

    Topics: Alcohol Drinking; Alkaloids; Animals; Azocines; Benzazepines; Male; Mice; Mice, Inbred C57BL; Nicotinic Agonists; Quinolizines; Quinoxalines; Varenicline

2013
Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 347, Issue:2

    Topics: Alkaloids; Animals; Azocines; Behavior, Animal; Benzazepines; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Drug Partial Agonism; HEK293 Cells; Humans; Male; Membrane Potentials; Mice; Molecular Structure; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline; Xenopus laevis

2013
Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:2

    Topics: Alkaloids; Animals; Azocines; Benzazepines; Infusion Pumps, Implantable; Male; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Varenicline

2014
[Safety of nicotine addiction treatment].
    Przeglad lekarski, 2013, Volume: 70, Issue:10

    Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia

2013
Nicotine and Cytisine Embryotoxicity in the Experimental Zebrafish Model.
    International journal of molecular sciences, 2023, Jul-28, Volume: 24, Issue:15

    Topics: Alkaloids; Animals; Azocines; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Varenicline; Zebrafish

2023